Stem Cell Pioneers: iPSC Discovery, Potential, and Manufacturing, Interview with Dr. Koji Tanabe

Dr. Koji Tanabe discusses IPS cell advancements, mass manufacturing, and their future in medicine.

iPSC/ESC, Manufacturing

July 29, 2025

Induced Pluripotent Stem Cells (iPSCs) hold great promise for regenerative medicine. These versatile cells can differentiate into nearly any tissue in the body, and their discovery earned the Nobel Prize in 2012.

In this interview, we talk with Dr. Koji Tanabe, the second author on the landmark human iPSC paper and founder of I Peace, a company working to make iPSC manufacturing significantly more affordable and accessible.

Dr. Tanabe shares insights on the journey leading to the discovery of iPSCs, their potential impact on healthcare, and how I Peace’s technology is helping bring down manufacturing costs.

Enjoy the interview!

Top Stories

Discover more from Regen Report

Subscribe now to keep reading and get access to the full archive.

Continue reading